Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125646181 | 12564618 | 1 | I | 20160704 | 20160718 | 20160718 | EXP | SE-AUROBINDO-AUR-APL-2016-09318 | AUROBINDO | 50.00 | YR | F | Y | 0.00000 | 20160718 | CN | SE | SE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125646181 | 12564618 | 1 | PS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | U | U | 77206 | FILM-COATED TABLET | ||||||||
125646181 | 12564618 | 2 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | U | U | 0 | |||||||||
125646181 | 12564618 | 3 | SS | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | U | U | 0 | |||||||||
125646181 | 12564618 | 4 | SS | Pramipexole Tablet | PRAMIPEXOLE | 1 | Unknown | .35 MG, UNK | U | U | 0 | .35 | MG | TABLET | |||||
125646181 | 12564618 | 5 | SS | DEVITRE | CHOLECALCIFEROL | 1 | Unknown | U | U | 0 | |||||||||
125646181 | 12564618 | 6 | SS | ORALOVITE | ASCORBIC ACIDNIACINAMIDEPYRIDOXINERIBOFLAVINTHIAMINE | 1 | Oral | UNK | U | U | 0 | FILM-COATED TABLET | |||||||
125646181 | 12564618 | 7 | SS | BETOLVIDON | CYANOCOBALAMIN | 1 | Unknown | 1 MG, UNK | U | U | 0 | 1 | MG | TABLET | |||||
125646181 | 12564618 | 8 | SS | FOLACIN /00024201/ | FOLIC ACID | 1 | Unknown | U | U | 0 | TABLET | ||||||||
125646181 | 12564618 | 9 | SS | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | 25 MG, UNK | U | U | 0 | 25 | MG | TABLET | |||||
125646181 | 12564618 | 10 | SS | LASIX | FUROSEMIDE | 1 | Unknown | U | U | 0 | |||||||||
125646181 | 12564618 | 11 | SS | DUODOPA | CARBIDOPALEVODOPA | 1 | Unknown | U | U | 0 | |||||||||
125646181 | 12564618 | 12 | SS | SINEMET | CARBIDOPALEVODOPA | 1 | Unknown | U | U | 0 | |||||||||
125646181 | 12564618 | 13 | SS | OPRYMEA | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | Unknown | 0.26 MG, UNK | U | U | 0 | .26 | MG | ||||||
125646181 | 12564618 | 14 | SS | SELEGILINE | SELEGILINE | 1 | Oral | 10 MG, UNK | U | U | 0 | 10 | MG | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125646181 | 12564618 | 1 | Product used for unknown indication |
125646181 | 12564618 | 2 | Product used for unknown indication |
125646181 | 12564618 | 3 | Product used for unknown indication |
125646181 | 12564618 | 4 | Product used for unknown indication |
125646181 | 12564618 | 5 | Product used for unknown indication |
125646181 | 12564618 | 6 | Product used for unknown indication |
125646181 | 12564618 | 7 | Product used for unknown indication |
125646181 | 12564618 | 8 | Product used for unknown indication |
125646181 | 12564618 | 9 | Product used for unknown indication |
125646181 | 12564618 | 10 | Product used for unknown indication |
125646181 | 12564618 | 11 | Product used for unknown indication |
125646181 | 12564618 | 12 | Product used for unknown indication |
125646181 | 12564618 | 13 | Product used for unknown indication |
125646181 | 12564618 | 14 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125646181 | 12564618 | LT |
125646181 | 12564618 | DS |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125646181 | 12564618 | Hypomagnesaemia | |
125646181 | 12564618 | Hyponatraemia | |
125646181 | 12564618 | Neuroleptic malignant syndrome | |
125646181 | 12564618 | Rhabdomyolysis | |
125646181 | 12564618 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |